| 1 |
Efficacy and Tolerability of Paliperidone Extended-release in the Treatment of First-episode Psychosis: An Eight-week, Open-label, Multicenter Trial |
|
| | Nam-In Kang,Bon-Hoon Koo,Sung-Wan Kim,Jong-Hoon Kim,Beomwoo Nam,Bong-Ju Lee,Sang-Hyuk Lee,Seung Jae Lee,Seung-Hwan Lee,Myung Hun Jung,Sang Woo Hahn,Young-Chul Chung | | | Clinical Psychopharmacology and Neuroscience. 2016; 14(3): 261 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
A Flexible-Dose Study of Paliperidone ER in Patients With Nonacute Schizophrenia Previously Treated Unsuccessfully With Oral Olanzapine |
|
| | MOSHE KOTLER,NESRIN DILBAZ,FERNANDA ROSA,PERIKLIS PATERAKIS,VIHRA MILANOVA,ANATOLY B. SMULEVICH,MARJOLEIN LAHAYE,ANDREAS SCHREINER | | | Journal of Psychiatric Practice. 2016; 22(1): 9 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Weight gain and antipsychotics: a drug safety review |
|
| | Richard Musil,Michael Obermeier,Paul Russ,Michael Hamerle | | | Expert Opinion on Drug Safety. 2014; : 1 | | | [Pubmed] [Google Scholar] [DOI] | |
|
